Skip to main content
Clinical Trials/NCT00748488
NCT00748488CompletedPhase 3

The ParkFit Study; Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease

Radboud University Medical Center32 sites in 1 country700 target enrollmentStarted: September 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
700
Locations
32
Primary Endpoint
Level of Physical Activity based on the LAPAQ questionnaire

Study Overview

Brief Summary

Patients with Parkinson's disease (PD) are heavily inclined towards a sedentary lifestyle. This is caused by a combination of physical impairments and cognitive dysfunction. However, regular physical activity in PD is highly desirable, for two reasons. First, physical activity has positive generic effects in preventing complications such as cardiovascular diseases, type II diabetes mellitus, osteoporosis and certain cases of cancer. Secondly, physical activity has additional disease-specific merits in PD such as depression, sleep disturbances and constipation. These effects lead to raised quality of life. Furthermore, animal studies suggest that physical activity could slow down disease progression.

Simply informing patients about the importance of physical activity is not enough to initiate and maintain an adequate level of physical activity. We propose to develop a physical activity promoting program for sedentary patients with PD in order to raise their level of daily physical activity.

Objective: The first aim of the study is to investigate whether a physical activity promotion program will result in an increase in physical activity in sedentary patients with PD.

The second aim is to demonstrate an increase in physical fitness and quality of life.

Detailed Description

no extensive description

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Idiopathic PD
  • •Hoehn and Yahr stage I-III
  • •Between 40 and 75 years old
  • •Not meeting the norm for healthy physical activity: the latter being defined according to international standards as either five days a week 30 minutes of moderate-intensity physical activity, or 3 days a week 20 minutes of vigorous-intensity physical activity

Exclusion Criteria

  • •Wheel chair bounded
  • •Severe co-morbidity (e.g. orthopaedic disorders or chronic hart failure)
  • •Severe cognitive decline, defined as Mini Mental State Examination < 24

Arms & Interventions

A

Experimental

Physical Therapy aimed to promote the level of physical activity

Intervention: Physical Therapy aimed to improve Physical Activity (Other)

B

Active Comparator

Physical Therapy aimed to move safely

Intervention: Physical therapy aimed to move safely (Other)

Outcomes

Primary Outcomes

Level of Physical Activity based on the LAPAQ questionnaire

Time Frame: Average of 6, 12, 18 and 24 months

Secondary Outcomes

  • Mobility (Timed up and go test)(12 and 24 months)
  • disease severity ( Nine Hole Peg test, UPDRS)(12 and 24 months)
  • Fatigue (FSS)(6, 12, 18 and 24 months)
  • Level of Physical Activity based on an activity monitor(continuous during 24 months)
  • Quality of Life (PDQ-39)(6, 12, 18 and 24 months)
  • Mood and Depression (HADS)(6, 12, 18 and 24 months)
  • Safety(Falls)(monthly)
  • Medication (questionnaire)(6, 12, 18 and 24 months)
  • One week diary of physical activity(Average of 6, 12, 18 and 24 months)
  • Physical Fitness (Six Minute Walk Test & Astrand bicycle test)(12 and 24 months)
  • Cognition (CANTAB)(12 and 24 months)
  • Medical Costs (questionnaire)(6, 12, 18 and 24 months)
  • Quality of Sleep (SCOPA-sleep)(6, 12, 18 and 24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

dr Marten Munneke, PT

Dr

Radboud University Medical Center

Study Sites (32)

Loading locations...

Similar Trials